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Abstract 
Normally developed thyroid function is critical to the transition from fetal to neonatal life with the 
onset of independent thermoregulation, the most conspicuous of the many ways in which thyroid 
secretions act throughout the body. A role for thyroid secretions in growth and maturation of the 
lungs as part of the preparation for the onset ofbreathing has been recognized for some time but how 
this contributes to tissue and cell processes and defenses under the duress of respiratory distress has 
not been well examined. Extensive arc hi val autopsy material was searched for thyroid and adrenal 
weights, first by gestational age, and then for changes during the first hours after birth as ratios to 
body weight. After a gestational age of22 weeks the fetal thyroid and adrenal glands at autopsy in 
those with hyaline membrane disease are persistently half the size of those in "normal" infants dying 
with other disorders. When the thyroid is examined shortly after birth it reveals a post natal loss of 
mass per body weight of similar orders of magnitude which does not occur in the control group. A 
clinical sample of premature infants with (12) and without (14) hyaline membrane disease was 
tested forT 4, TSH, TBG, and total serum protein. The results also demonstrate a special subset with 
lower birth weights at the same gestational age, and lower serum T4 and total serum protein_ 
Ventilatory distress in newborn rabbits was induced by bilateral cervical vagotomy at 24 hours post 
natal following earlier injection of thyroxine (T4) or thyroid stimulating hormone (TSH) and 
comparisons were made with untreated animals and by dose. Early life thyroidectomy was 
performed followed by exposure to either air or 100% oxygen. A final experiment in air was 
vagotomy after thyroidectomy. Composite analysis of these methods indicates that thyroid factors 
are both operative and important in the newborn animal with ventilatory distress. This work and 
the archival data indicate those infants destined to develop hyaline membrane disease through 
respiratory distress are a distinct developmental and clinical subset with the point of departure from 
otherwise normal development and maturation in the second or early third trimester. This interval 
is known to be a period of marked variation in the overview indicators of fetal progress through 
gestational time. The initiating factor or circumstance which then separates this special subset from 
normal future development is placed by these observations firmly into the period when human fetal 
TSH dramatically rises 7-fold (17.5-25.5 weeks) followed by a lesser 3 to 4 fold increase in T4 
which is extended into the early third trimester. The earlier part of this interval is characterized by 
the thyrotrophic action of chorionic gonadotropin (hCG). The possibility that abnormalities in the 
intrauterine environment secondary to maternal infection play a role within this time frame is 
indicated by the demonstration that interleukin-2 (IL-2) induces an anterior pituitary release of 
TSH. Since IL-2 has this property and is not an acute phase cytokine, some form of chronic 
infection or an immunopathic process seems more likely as a possible active factor in pathogenesis. 
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Introduction 
Earlier work from this laboratory demonstrated a complex but systematic relationship between the 
amount of oxygen to which the lung was exposed and the extent and severity of lung injury in a 
neonatal animal model for hyaline membrane disease (Shanklin, 1969; Shanklin and Lester, 1972). 
The model is based on the effects of bilateral cervical vagotomy (BCV) on the lung (Farber, 1937). 
When Farber's model using adult rabbits is transferred to the newborn rabbit the resulting lesion is 
that of human neonatal hyaline membrane disease (Shanklin and Berman, 1964 ). The frequent 
occurrence of intermediate severity of the lesion in the model offered a way to ascertain certain 
pathogenetic factors of importance. 
Firstly, the physiological concept of the effects of the partial pressure of gases was shown to be a 
consequence of normobaric environments at one atmosphere absolute ( 1.0 AT A) at or near sea 
level. These experiments used oxygen at 7, 21, 40, and 60 percent against nitrogen, and at 1 00% 
oxygen in hypobaric (0.2 and 0.6 ATA), normobaric, and hyperbaric (3.0 ATA) total pressure 
(Shanklin, 1969). 
Secondly, the oxygen effect is dependent on which second gas was used as diluent in the inhaled 
mixture. In these circumstances, oxygen at 20 and 60 percent was studied with argon, helium, neon, 
and nitrogen, and also at 20, 40, 60, and 80 percent against sulfur hexafluoride. The results were 
then compared to those from 100% oxygen (Shanklin and Lester, 1972). 
Extensions of the work using the same gases, and hydrogen, at oxygen percentages lower than the 
atmospheric 20-21% will be reported elsewhere. 
The discussion of the diverse but systematic effects by diluent gas considered five sites and the 
categories of physical and physicochemical attributes of each gas likely to be operant there, seeking 
thereby to identify one or more factors in the process of injury to the lung observed in this model. 
These were: (a) the external body surface and thermal conductivity with metabolic effects, (b) the 
conducting airways, mediated by flow dynamics including turbulence, (c) the gas-tissue interface, 
at which a stochastic or coordinated competition from the specific mix of the inhaled gas mixtures 
was the controlling factor, (d) within the pulmonary tissue itself, without specifying at what level, 
and (e) systemically, mediated through metabolic consequences with secondary injury to the lung 
(Shanklin and Lester, 1972, pp. 149-150). 
Two of these sit.es, external body surface and systemic effects, readily imply participation of animal 
metabolism as a feature, whether by a direct pathogenetic role, as an adjunct factor, or as a 
supplement to the more obvious effect of the percentage of oxygen in any given inhalant mix 
(Shanklin and Lester, 1972). A third, prospect (d), within the pulmonary tissue itself, would relate 
to specific aspects of pulmonary metabolism. The data presented in that report did not allow further 
definition of the matter (Shanklin and Lester, 1972). 
The question arises whether such metabolic effects are due to activation or participation of ordinary 
metabolic reactants, such as thyroxine (T4), or triiodothyronine (T3), or the size of the animal 
subject, or both, or some other feature. The animal model used in these studies introduces a 
metabolic factor in that no nutritional or fluid support is provided between birth and vagotomy, or 
after the procedure. Little is known about the effects of immediate postnatal nutrient deprivation, 
especially in premature infants, a state once very common in clinical practice (Stone, 1945), and, 
from their important distinctions from adults, even pregnant adult women, the lessons from short 
term fluid and caloric deprivation in adults may not be directly applicable (Felig, et al., 1969; Felig, 
et al., 1972; Kim & Felig, 1972). 
Maternal starvation in rabbits for 48 hours prior to delivery has profound effects on the newborn 
rabbits, with higher blood concentrations of free fatty acids and triglycerides and a greater maximal 
rate of heat production over the first three days after birth (Edson and Hull, 1977). Normalization 
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of glycogen reserves in man, monkeys, sheep, pigs, dogs, rats, guinea pigs, and rabbits reveals that 
the rabbit has the lowest hepatic storage of these eight species, circa 35 mg/gram wet weight liver, 
and that this falls dramatically the first day after birth even when the newborn has suckled (Shelley, 
1961). Total carbohydrate reserves in infants dying with respiratory distress syndrome/hyaline 
membrane disease were consistently lower in heart, liver, diaphragm, and leg muscles, very roughly 
about half that found in deaths from non-respiratory causes (Shelley, 1964 ). 
Thyroxine has decided effects on the fetal lung when applied in certain ways in rats (Redding, eta!, 
1972; Sosenko and Frank, 1987), rabbits (Wu, et al., 1973), and from indirect evidence, in humans 
(Mashiach, et al, 1978; Redding and Pereira, 1974). A principal result is enhanced histologic 
maturation when given directly to the late developing fetal rat (Redding, et al., 1972) or rabbit (Wu, 
et al., 1973), but not when given to the dam or doe (Wu, et al., 1973). Another effect pertains to 
maturation of lung permeability (Barker, eta!., 1990; Hemberger and Schanker, 1978). It should 
be noted that most such experiments consider only the effect of additional T4, T3, or thyrotropin (TSH) which may override the usual physiologic homeostatic mechanisms. The result may be 
considered as an induced dysthyroidal state roughly comparable to the dysthroidism of progressive 
fetal failure of cellular development with coordinated function of the thyroid axis. The relation of 
thyroid tactors to oxygen challenge has been explored with thyrotropin releasing hormone (TRH) 
in rats, but without the added factor of induced ventilatory distress (Rodriguez, et a!., 1991; 
Rodriguez-Pierce, eta!, 1992). Described here are the effects ofT4, TSH, and thyroidectomy in the 
newborn rabbit under various circumstances. T4 was chosen instead of T3 to invoke the normal 
processes of conversion in vivo. 
These aspects have to be placed in the context of normal but dramatic changes in the regulatory 
matrix of thyroid function upon birth .. First, there is an acute release of TSH in the human newborn, 
from a mean value of9.5 ~-tU/ml in cord blood to 86 ~-tU!ml in the neonatal circulation within 30 
minutes after birth (Fisher and Odell, 1969). Second, cord blood has low T3 and high T4 
concentrations with a sharp rise in T3 from 51 ± 3 ng/1 00 ml in cord blood to 191 ± 16 ng/1 00 ml 
in neonatal blood at 90 minutes after birth (Abuid, et al., 1973). The change in T4 is minimal at 90 
minutes, from 12.2 ± 2.0 ~-tg/100 ml cord blood to 14.1 ± 1.9 ~-tg/100 ml in the circulation (Abuid, 
eta!., 1973). The timing and slope of these plots indicates the surge in TSH precedes and promotes 
the increase in T 3. Reported here are the results of 26 premature newborns, 14 controls that did not 
show signs of respiratory distress and, 12 that did. The birth values of serum T 4 , TSH, TBG, FTI, 
and total serum protein, are examined against gestational age, birth weight, and Apgar Scores. 
-' The evolutionary aspects of thyroid factors has been examined in part. Changes occur in both 
structure and function of the gi 11 of the teleost fish Ana bas testudineus (Bloch) depending on thyroid 
status (Sreejith, et al., 2007). 
This paper considers the role of thyroid factors in the pathogenesis of hyaline membrane disease 
in the premature infant. Specifically, data are presented on these five subjects: 
[1 J the growth of the human fetal thyroid and immediate postnatal loss of glandular mass, 
[2] the parallel growth of the human fetal adrenal glands as a surrogate marker for fetal 
glucocmticoid resources, 
[3] the influence of weight loss between bitth and surgery on the further weight loss after BCV 
or other experimental interventions as a marker for metabolic drain, 
[4] the effect ofT4 and TSH on outcome following bilateral cervical vagotomy to induce 
respiratory distress, 
[5] the effect ofthyroidectomy on survival and lung injury with and without added oxygen and 
when followed by vagotomy. 
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Materials and methods 
Archival studies: 
During twelve years as pathologist-in-chief in the Laboratory of Pathology, Chicago Lying-In 
Hospital (CLIH) (1967-1978), the opportunity arose to review in detail the cumulative records 
compiled by my predecessor, Edith L. Potter, M.D., Ph.D., (1901-1993) through the modality of the 
City of Chicago Perinatal Mortality Study initiated in the mid-1930s by Herman N. Bundesen, 
M.D., Sc.D. (1882-1960), long time Commissioner of Health of Chicago. Approximately 7,500 
autopsy records were on file in this archive. 
Further review was enhanced by having the records converted to microfiche by the University of 
Chicago Joseph Regenstein Library Department of Photoduplication, after a first reading of the 
archive. Whilst all records were not complete for data pertinent to this work, most were useful in 
many ways. In numerous cases, stillborn and newborn, there were descriptions of microscopic 
slides, complete autopsy reports, and a few details from the clinical course. Intrapartum stillbirths 
were very common in the earlier years of the Potter archive. These latter were excluded from this 
review when weights were either absent or only of the major organs. Since this was not an 
epidemiological study no attempt was made to ascertain the proportion of cases excluded while 
seeking to fulfill certain quotas as generally representative of the whole. 
The records on microfiche were thoroughly reviewed four times. The first review was retrograde, 
comparing newborn adrenal and thyroid organ weights between infants with hyaline membrane 
disease (HMD) and those dying from other causes on a gestational age basis, but excluding major 
malformation syndromes. This review obtained 450 premature newborns, 154 with hyaline 
membrane disease at autopsy and 296 without HMD. This information was placed in a spread sheet 
(ProStat v4.51 for Windows, Poly Software International, Pearl River, N.Y., 10965) [Table 1 and 
Figure 1]. The second review revisited the database from its origin to ascertain whether the thyroid 
to body weight ratio changed with survival time after birth. This time period was chosen to minimize 
any possible effect from immediate postnatal treatment. The third and fourth reviews were dedicated 
to verification and to the capture of any overlooked pertinent material. 
Thence, phase one ofthe second review was to create a similar spread spreadsheet with four subsets 
of information: [ 1] nonmacerated late stillborns, to ascertain the baseline at the end of intrauterine 
life, [2] newborRS with conditions other than HMD, [3] newborns with histological diagnoses of 
or findings con.sistent with pulmonary edema, a precursor to HMD (Shanklin, 1959; Shanklin, 
1964 ), and [ 4] newborns with a histological diagnosis or findings consistent with hyaline membrane 
disease per se. 
After subsets [1] and [2] obtained one hundred cases each, preliminary analysis showed newborns 
dying in the first 30 minutes could not be easily distinguished by time analysis from the stillborn 
subset (data not shown); most represented the singular failure of onset of respiration. These cases 
differed enough from those surviving over 30 minutes that this early subset was set aside and the 
newborn analysis was extended to obtain 100 cases each. This required reviewing 906 cases overall. 
A slower rate of accession occurred in cases with pulmonary edema (PE) and HMD from the initial 
four year archive 1934-193 7. The quota of 50 cases of PE and HMD required extending the first 
phase through 1942. The number of records over these time frames which were reviewed in order 
to obtain the data is shown in Table 2. 
Weight loss in experimental animals: 
Newborn rabbits were weighed at birth, at the time of vagotomy, and at autopsy. This generated 
data for determining the rate of loss of weight for each interval and each experiment. The results are 
reported as the slope of loss regressions for comparison. 
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Laboratory assessment of premature newborns: 
Following approval by the Institutional Review Board under an expedited protocol for collection 
ofblood samples, 30 premature newborns were sampled at birth for total serum protein (Lowry, et 
al, 1957) and for T4, TSH, thyroid binding globulin (TBG), and free thyroxine index (FTI) in the 
hospital clinical laboratory by methods in common use at the time with internal standards and 
controls (Cassidy, et al., 1968; Henry, 1984; Man, et al., 1969). Four of the control cases were in 
a much higher weight range beyond those with hyaline membrane disease and these were omitted 
from analysis for a better comparison. 
The basic animal model (BCV) and preparation: 
Pregnant New Zealand and Dutch rabbits at term were induced by oxytocin (Shanklin, 1966). 
Immediately after delivery the newborns were placed in air in incubator boxes at 34°C with 50% 
relative humidity, separate from the doe. They were maintained there until 24 hours of age without 
caloric supplementation. At 24 hours all animals were subjected to bilateral cervical vagotomy as 
previously described (Shanklin and Berman, 1964; Shanklin and Sotelo-Avila, 1967). Almost all 
vagotomies took less than one minute to complete, including positioning and restraining the subject 
for the procedure. A few drops of dilute local anesthetic were used in all cases (Shanklin and 
Berman, 1964; Shanklin and Sotelo-Avila, 1967). 
Close observation of all animals was maintained. Animals were removed after death and were 
autopsied according to the methods and procedures previously reported (Shanklin and Berman, 
1964; Shanklin and Sotelo-Avila, 1967; Shanklin, 1969). In brief, the extent of lesion was 
determined by a grid approximation .formula on the pleural surface of the lungs, with each of the 
four principal lobes considered separately. These values were combined by a weighted formula in 
which each upper lobe was one-sixth and each lower lobe was one-third of the whole. Estimates 
were enabled in part because the grossly apparent reaction discretely follows lobular lines. The 
result is a percentage of total pleural surface. The determination was performed under a dissecting 
microscope at 15-30X to verifY airlessness and fluid collection of each lobular zone. Lungs were 
fixed in Bouin's fluid and the lesions were then confirmed microscopically. 
Thyroidectomy: 
This was performed at two hours after birth. The external surgical approach was the same. After 
the trachea was identified and isolated bilaterally, careful dissection of the thyroid gland was 
commenced from the dorsal edge of each lobe and final detachment of the gland from the trachea 
was at the ventral interlobar isthmus. The minimal blood loss was compressed briefly by small 
sterile gauze pads. Generally, the procedure was completed within three minutes. 
Thyroxine: 
Injectable L-thyroxine (T4) Flint was obtained from the hospital pharmacy and was administered by 
dorsal subcutaneous injection between the scapulae in doses of 1.0, 1 0.0, or 100.0 mg/kg body mass. 
The injections were at three hours post natal. 
Thyrotropin: 
Injectable thyrotropin (TSH) Armour was also obtained from the hospital pharmacy and was 
administered by dorsal subcutaneous injection between the scapulae in doses of 0.1, 1.0, 1 0.0, or 
100.0 mU/kg body mass. The injections were at three hours post natal. 
A total of 245 newborn rabbits was used in the specific experiments reported here, including 126 
BCV air only controls for comparison. 
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Assignment of animals from given litters to a group was as before, with special attention to large 
litters and by weight (Shanklin, 1969). The sex ratio of individual groups was left to random sort 
by the minimum test group size as noted above (Shanklin and Berman, 1964; Shanklin and Sotelo-
Avila, 1967; Shanklin, 1969) since the sex of the newborn animal is readily determined only at 
autopsy. 
Analysis by litter, weight, and sex showed no inherent bias to the distribution, with random, or 
nonsystematic placement between comparable, adjacent, and sequential groups. 
Graphic and statistical analysis: 
The time intervals postvagtomy as used in this text were taken as a whole and as particular segments 
of the survival curves, A, B, and C, in time sequence order. Extensive prior experience had shown 
a triphasic response when the per cent surviving as log10 (on the ordinate) is plotted against the 
survival in hours (on the absicissa) (Shanklin, 20 I 0). Mean gross long change (GLC), the extent 
of the lesion which results from the experimental intervention, was considered as the mean ± the 
standard error of the mean (SEM) for the whole set as well as each subset, when appropriate .. 
The slopes of phases A, B, and C were calculated from the log scale conversions. Where useful, 
Student's t test and Chi-square testing was applied for small sample comparisons. Values of pare 
reported as one-tailed tests of significance since the origin of all such scales is theoretically zero 
with a unidirectional time vector. Areas under the survival curves was determined by printing the 
graph on quadrille paper and measuring the result in centimeters with square counts at uneven plot 
lines (Shanklin, 201 0) . The result is reported in arbitrary units of area. 
Global analysis by statistical means (± s.e.m) has little meaning in light of the differences in the 
slopes and intercepts of the three phases and was not used. Rather, the comparisons are by survival 
against time and by extent of pulmonary lesion for each time frame. 
Formal analysis and graphs were done with the aid of ProStat 4.51 and 5.5 for Windows (Poly 
Software International, Inc., P .0. Box 80, Pearl River, NY I 0965), as noted for archival studies; 
preliminary graphs and slopes of regression equations were calculated using Abstat 5.0 for DOS and 
1.96 for Windows (Anderson-Bell Corporation, P.O. Box 745160, Arvada, CO 80006);. 
The experimental protocols were approved by the relevant animal research committee of the 
University of Chicago, the recipient of the grants-in-aid as noted. 
Results 
Archival studies by gestational age: 
The first phase of review sought the size of the thyroid and adrenal glands on a gestational age basis. 
As noted, a total of 450 cases were enrolled starting in the mid-1960s and working backward in time 
The following table and graph shows progressive divergence of the thyroid:body weight ratio and 
similar changes in adrenal weight. [Table 1, Figure 1 ]. This total included 154 autopsy proven cases 
of hyaline membrane disease and 296 control autopsies, excluding known syndromes and gross or 
global anomalies. 
The data show close similarities for birth weights before 31 weeks and progressive disparity 
afterwards. The crown-heel and crown-rump lengths are much closer numerically. There is also 
a consistent higher proportion of males in the HMO cases which is typical of the disorder (Shanklin, 
1963), a factor relevant to the role of sex hormones, especially estrogens, in the pathogenesis and 
progression of the respiratort distress syndrome (Shanklin and Wolfson, 1970). The most striking 
feature is the lower absolute weight of the thyroids for the infants with hyaline membrane disease. 
The difference in thyroid weight at 22-27 weeks is statistically significant at p<0.02 and the overall 
trend is highly significant, p = 0.001. The difference in adrenal weights shows divergence later at 
--
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28-30 weeks gestational age. The p values for differences in adrenal weights are in Table 3. 
When the absolute weights are normalized against the top mean weights for thyroid and adrenals 
the striking persistence of the differential is shown graphically [Figure I]. 
In the second phase of the Potter archive a total of 4,588 perinatal autopsies from 1934 through 
1942 was reviewed [Table 2]. As accessions grew (the busiest year was 1938 with 830 perinatal 
autopsies) more and more hospitals in Cook County, Illinois, and the City of Chicago, participated 
in the Bunde sen program. Eventually 53 hospitals other than the three CLIH services (the CLIH in 
house obstetrical service, the CLIH Home Service, and the Chicago Maternity Center) were 
registered. Of the 53 "outside services" the most important was Provident Hospital which had an 
informal arrangement with CLIH staff. The outside hospitals contributed 2,827 cases of which 
2,154 (76.19%) had sufficient data for assessment. The three main sequence services contributed 
1,751 cases of which 1,717 (98.06%) had the appropriate particularities. Table 4 has further details 
of the cases by stillborns and newborns, the latter with and without hyaline membrane disease. 
This table might seem to suggest a paradox, that the university obstetrical services had a higher 
stillbirth experience but this is an artefact from the higher frequency of complete reports which also 
displayed a higher rate of respiratory distress syndrome/hyaline membrane disease [Table 5]. 
When presented in graphical form an interesting pattern and differences in the prevalence of the 
lesions between the CLIH services and the outside hospitals emerge [Figure 2]. 
Thvroid gland weight loss shortly after birth: 
The thyroid: body weight ratios had very different profiles between infants with hyaline membrane 
disease and those without. The latter had a flat mean line from birth through 230 hours post natal, 
with a regression confirmed ratio of 0.005200 (plot not shown). By contrast infants with hyaline 
membrane disease displayed a biphasic curve, with a change point at 12 hours. The normalized ratio 
change from 0 to 12 hours was minus 30.9% with a total decline by 66 hours of68.2%. The ratio 
at 66 hours, by regression analysis, was 0.0025291. The equation is part of the legend for Figure 
3. Thus, the immediate post natal change brought the relationship into the range of the overall 
distinction over gestational time as shown in Figure 1, offering as one possibility the difference is 
due to immediate post natal effects after the first 30-60 minutes. 
Circulating thyroid factors and serum protein in premature newborns: 
Preliminary study revealed several controls with birth weights well above the highest of the 
respiratory distress (RDS) subset (N == 4); these were set aside for direct comparison of the 
others, a final total of 26 cases, 14 normal controls and 12 infants with respiratory distress 
syndrome by clinical and radiological criteria. This adjustment actually reduced the significance 
of the two group comparison of birth weights. Remarkably, a highly significant difference was 
observed in the Apgar Scores of these premature infants [Table 6]. 
When the Apgar scores are plotted against birth weight (data not shown) there is a flat plot for 
the control scores but a steady increase by birth weight for the hyaline membrane cases. This 
might be construed to suggest the maturational vectors for immediate post natal adaptability are 
normally well developed early in gestation but are much retarded in those fetuses which manifest 
respiratory distress at and soon after birth. 
This subset of premature newborns with respiratory distress syndrome are also a distinct thyroid 
arena with respect to birth weight, serum thyroxine, and total serum protein [Tables 7a and 7b]. 
The difference in birth weight is noteworthy, even by inspection, and the difference in T4, 1.18 
f.!g/d1, is a decrease of 15.57% from the control. This is significant at p == 0.0455. By contrast, 
--
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the difference for TSH is smaller at 9.53% (1.04 ~g/dl), and is not significant, t = 0.82, p = 
0.2125. 
The total serum protein had a very different range and a significant mean difference [Table 7b]. 
The range of gestational ages for RDS/HMD cases began a month earlier but the mean 
gestational age is not statistically different. The controls had a range of 28-38 weeks against 24-
37 weeks for RDS/HMD cases. The means were 33.71 ± 0.822 and 31.58 ± 1.311 weeks 
respectively. The difference, 2.13 weeks, is not significant (p = 0.844). The median gestational 
ages were 33.5 and 32.0 weeks, respectively, a difference of 1.5 weeks. 
Although a limited study, in comparison to the archival data, important differences are seen in 
infants with respiratory distress syndrome, viz, lower birth weight, lower total serum protein, and 
lower T4 values, and in clinical manifestations of birth adaptability as is summarized by the 
Apgar score. By contrast, although TSH, FTI, and thyroid binding globulin were all a little 
lower in HMD/RDS cases, they were not significantly so (p = 0.2125, 0.1760, and 0.0698, 
respectively). Finally, 10 of the 12 HMD/RDS cases were managed in part by enhanced oxygen 
environment at 30-60%, against none of the 14 non-HMD/RDS infants. 
Experimental results following prevagtomy thyroxine: 
One hundred twenty six newborn rabbits in a fasting state were subjected to bilateral cervical 
vagotomy at age 24 hours with air as the inhalant gas, the control group. As previously reported, 
animals from birth to BCV and after surgery were maintained in an incubator set at 34 oc and 
50% relative humidity (Shanklin anq Sotelo-Avila, 1967). Each batch of four to six animals was 
followed to their demise and the lungs were examined and the autopsy weight determined. 
Survival analysis showed this particular control subset to have followed the same pattern of 
demise as every prior air only subset studied over the years (Shanklin and Berman, 1964, 
Shanklin and Lester, 1972, Shanklin, 201 0). This control experience is the baseline in Figure 4. 
Table 8 displays the mean and median survival of the control group, values which are very 
similar to those previously observed in air only treatments following BCV (Shanklin and 
Berman, 1964; Shanklin, 1969; Shanklin and Lester, 1972; Shanklin, 201 0) as well as post 
thyroxine and post thyrotropin at 3 hours of age. The group control mean lung change was 7.70 
± 1.56 per cent of lung surface. Subset means were: Phase A, 4.23 ± 1.05, Phase B, 33.6.62 ± 
10.68, and Phase C, 43.00 ± 7.93 per cent. Despite the large standard error for Phase B (the 
result of only 6 animals in the group), the difference between Phases A and B was significant, t = 
6.11593, p = < 0.0001. The further difference between Phases Band C was not significant, p = 
0.2519. 
Thirty six newborn rabbits in a fasting state were injected at age 3 hours with thyroxine, 12 at I 
mg/kg, 13 at 10 mg/kg, and 11 at 100 mglkg. These were then compared to the air only post 
BCV control set of 126 similar animals. After subset analysis of the survival curves, which 
revealed little difference by dose as to survival, the data were then combined into a single data 
set [Figure 4]. Phase A after pre-BCV thyroxine was dramatically shortened, giving the curve a 
much higher profile prior to a sharp decline in Phase C. The mean survivals were very different. 
The control mean was 6.87 ± 1.14 hours with a median of 3.00 hours. The combined thyroxine 
mean survival was 19.92 ± 3.07 hours, with a median of 14.1 hours. Table 9 compares just the 
mean values (no SEM) for all of the subsets by dose and phase following thyroxine to the whole 
thyroxine and control observations. When viewed graphically (not shown) several points found 
in the tabular data deserve attention. Mean lung change in Phase C at 1.0 mg/kg thyroxine 
appears low for late survivors but can also be viewed as beyond the influence of the least dose 
utilized. Although there is little difference in the mean survival in Phase A, they bear a precise 
linear relationship in the semi-log plot. The same is true for both survival and lung injury in 
Phase B. The smallest group in all experimental runs is Phase C and although the basic change 
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in late survival is always abrupt over a relatively short interval, comparisons of lung change and 
other features is sometimes less assured than at earlier times in the experiments. 
The negative or harmful effects of middle range (10 mg/kg) and high dose (100 mglkg) 
thyroxine in this system are well shown in Phase A. The gross lung change at 10 mglkg in Phase 
A is 20.77%, 2.49 times the result at 1.0 mg/kg, and 25.90% at 100 mg/kg, 3.1 times the lowest 
value. As noted above, this is an exponential correlation against the log dose of thyroxine 
[Table 9]. By contrast, the mean lung injury are elevated in the 25-33% range during Phase B, 
the differences having a linear relationship to log10 dose. These values combine in the entire 
thyroxine result shown in Figure 5. 
Experimental results following prevagotomy thyrotropin: 
As seen in Figure 4, thyrotropin elicits a survival profile different in important ways from either 
controls or thyroxine effects. First, the proportion of animals dying in Phase A is intermediate 
between the other two subsets and conversion to Phase B occurs slightly later in time. Second, 
Phase B is greatly prolonged such that conversion to Phase C occurs past 65 hours post-BCV. 
Moreover, the pattern of lung change has a distinctive profile, with the result at 10 mU/kg 
markedly lower than the other three dose levels [Figure 6]. The figure offers the suggestion this 
is a presumptively optimal protective dose level since both lower doses and the maximum, 100 
mU/kg, all have mean gross lung injuries in the uppermost percentage ranges of the entire study 
following vagotomy as the only surgical intervention, viz, over 20% 
The high variation prompted several recalculations dropping one or more subsets from 
consideration but these had only Il,linor effects on the profile of the survival curve so all four 
were left intact as a composite group for presentation [Figure 4]. 
Table 9 shows the composite mean survival to be 15.09 hours, less than that for thyroxine 
which is explicable with a longer Phase A but mean gross lung change just 1.05 times higher 
than the thyroxine effect (22.46% vs. 21.3 8% ). These are, in effect, the same value. Of much 
interest is the ratio between the areas under the curve [Table 8], 1.02, again, in effect, the same 
value. It appears both pre-BCV treatments have the same appreciable effect on survival and 
lung injury, the differing modality and position in the operational scheme of their physiologic 
actions notwithstanding. When taken together in comparison to the controls, a striking pattern 
does emerge. _The areas under the survival curve are 1.47 (thyroxine) and 1.50 (TSH) of the 
control value [Table 8] but the extent of lung injury is 2.78 (thyroxine) and 2.92 (TSH) time 
that of the control result [Table 1 0]. 
From this aspect alone one is entitled to conclude, both thyroxine and thyrotropin in 
pharmacological doses promote lung injury well beyond the deleterious effects of induced 
respiratory distress. The probing exception is 1.0 mg/kg thyroxine in Phase C, a lung change of 
7.0%, no different than the overall control mean, about one sixth of that in Phase C in the 
controls. It is tempting to conclude the effect of added thyroxine at this level has worn off, the 
lung reverting to a Phase A status, were it not for the equally demonstrable fact that the actual 
Phase A injury after 1.0 mglkg thyroxine was 8.33%, not significantly different from the control 
value. Exhaustion or downregulation of the pertinent receptors or the feedback loops is a more 
likely arena for explanation of the result in the final phase of response to this thyroxine dose, if 
they are involved at all. Thyroxine in this system appears to be working as a drug; the added 
thyrotropin seems to be mixed in with the thyroid stimulating and modulating events that 
normally follow birth. 
Experimental results following thyroidectomy: 
Thyroidectomy two hours post natal was performed to approximate total acute thyroid failure but 
necessarily leaves intact, at least transiently, the residual actions of circulating and already 
--
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receptor and protein bound T 4, T 3, and TSH. Eighteen newborn rabbits were thyroidectomized 
and placed into chambers with either air (I 0) or I 00% oxygen (8). A vastly different survival 
pattern emerged [Figure 7], which, by visual inspection, lacks Phase A characteristics. The two 
runs followed closely similar survival curves which could not be distinguished except by 
duration with a distinctive distribution [Table I 0]. There is a displacement in what resembles 
Phase B at 46 hours post thyroidectomy (at age 48 hours) which may be explained by the 
distribution difference between air and oxygen exposures. The distribution is highly significant 
by J!, p = 0.0073. The mean survival of the thyroidectomy-air subset (Figure 7) contains the 
comparison of these I8 animals to two then subjected to BCV after 22 hours in air (the timing of 
vagotomy was the same as in the animals depicted in Figure 4 ). Both survived BCV by about 
one hour and revealed advanced gross lung change, remarkably both at 52% but with different 
lobar distribution. This dramatic result prompted no further dual surgeries since the main 
interest was in a comparison between oxygen and air effects on the thyroid ablated animals. 
However, when placed in a weight loss graphic, they fit exactly due to the very short survival. 
In the full series of 20 animals, overall weight loss was 26% on a reasonably steady linear slope 
( -0.00244806) with two outliers, both late air survivors (data not shown). The characteristic 
previously demonstrated of life prolongation due to oxygen (Shanklin, 20 I 0) is suggested also 
by this distribution. Although the mean gross lung injury is highly variable it shows strong 
trends in this small sample. That in oxygen was twice that in air, 2.04 times [Table II] but with 
p = 0.07I3. When the survival time frame is limited to those beyond 48 hours, the ratio rises to 
2.33, but with p = 0.1I80, showing the effect of the smaller sample. The lesser difference in 
survival (mtio = 1.288) between both groups taken as a whole, is closer to significance, as a 
unidirectional variable, with p = 0.0603. The difference in mean survival after 48 hours is not 
significant, as expected (p = 0.2948). 
Discussion 
The foregoing experiments, archival review, and clinical study well establish four conclusions: 
[1] Thyroid factors are involved in the respiratory distress of newborn humans and rabbits; 
[2] Thyroid factors are operative within the context of a background metabolic deprivation state 
which is intrinsic to the animal experiments as performed and which may be present in 
the underweight fetuses illustrated in Table I and Figure 1; 
-
[3] There is a distinct subset of human premature newborns whose development and functional 
status eventuates in respiratory distress clinically and in hyaline membrane disease 
pathologically which is reflected in archival autopsy studies and in concurrent clinical 
observation; and 
[ 4] Although there is an overall aspect shown in experimental studies of the thyroid arena, there 
is variability of a sort which might be best understood by factors not under investigation. 
There is also and appropriately, variation in the results in hospitalized premature newborns, and 
in the archival autopsy database. These variations often emphasize aspects of the pathogenetic 
network which, if not the cause of the disease, are clearly important parts of the framework. The 
fetal thyroid develops and matures along certain general lines across gestational time but is 
subject to variations of pattern, size, and function; it is also influenced by other tissues and 
organs and pathological states of the fetus [Figure II]. Thyrotoxicosis has been described in 
utero, apparently the same lesion shown in Figures llB and 11D (Serup and Petersen, 1979). 
And, intrauterine 131! treatment has been implicated in neonatal thyroid agenesis (Exss and 
Gmewe, I974). Maternal thyroid status does influence the growth and development ofthe fetus 
(Mestman, et al., 1969). Finally, abnormalities of brain development which interrupt the 
formation and maturation of the hypothalamic-pituitary axis often result in atypical thyroids 
(Shanklin, 1991 ). 
Page 10 
Overview of the results: 
The onset of breathing and balanced regulation of ventilation are the imperative challenge at 
birth in newborn animals and human infants (Jansen and Chernick, 1988). As to these 
experiments and archival studies, the results in general validate the investigation of the whole 
animal once it became apparent both thyroxine and TSH, although given on a pharmacological 
challenge basis, had their effects through disturbance of thyroid homeostasis without putting it 
beyond all aspects of normal function. Perhaps near the head of a list of necessary functions is 
the question of the duration of effects of T4 and TSH. This has not been expressly studied in 
newborn rabbits or infants, more especially those in respiratory distress but the question has been 
investigated in adult rabbits (Brown-Grant, et al, 1954), adult sheep (De Pablo-Davila, et al, 
1980; Miralles-Garcia, et al, 1981 ), and in adult rats (Hintze, et al., 1991; Kaplan and Yaskoski, 
1980; Larsen and Frumess, 1977; Nathanielsz, 1971). 
Systemic disease alters the peripheral conversion of thyroxine to triiodothyronine (De Pablo-
Davila, et al, 1980; Miralles-Garcia, et al, 1981 ). The kidney is especially important in thyroid 
metabolism through: (a) excretion of the hormones and metabolites in the urine and as a major 
site for extrathyroidal conversion of T4 to T3 (De Pablo-Davila, et al, 1980) The normal 
elimination stage half-life for T4 was reported as 33.4 ± 4.4 hours. The comparable half life of 
T4 in induced acute liver insufficiency studies from the same laboratory (Mirales-Garcia, et al., 
1981) was 26.9 ± 3.5 hours. Physical and emotional stress was applied to adult rabbits by 
Brown-Grant, et al (1954) including laparotomy, physical restraint, intraperitoneal turpentine, 
and induced hemorrhage, They primed rabbits with 1311 and then followed the thyroid release of 
radiolabeled T4 under various con~itions. The release periods ranged from 20 to 40 hours. 
Nathanielsz (1971) approached this from the standpoint ofthe thyroxine distribution space in the 
adult rabbit, a statement ofthe circulating pool of [1251] T4, not the rate of secretion. The half life 
of T4 in this compartment was 11 hours. Significantly, the rate of conversion of T4 to T3 was 
significantly reduced in rats fasted for 48 hours (Hintze, et al, 1991). More recently, Nagao, et 
al. (2011), demonstrated an effect of thyroidectomy on thyroxine metabolism and turnover in 
seven week old Sprague-Dawley rats. Injection of radiocarbon labeled thyroxine (13C9)T4 was 
followed for 17 days. In normal rats the labeled T4 had cleared by the fifth day whereas in the 
post thyroidectomy animals it took nine days to clear and after two days peripheral T4 stabilized 
from the release of thyroxine from peripheral tissues (Nagao, et al., 2011). Their results 
translated into_ a half life in the controls of 14.16 hours and 27.84 hours following 
thyroidectomy. 
Whilst not precise in terms of time frame nor from newborn rabbits as a direct comparison 
model, these several time intervals fit reasonably well to those which resulted from the 
experimental side of this report. 
The Potter Archive: 
There are no studies of comparable nature, size, or by historic period to the Potter Archive. 
Changes in the clinical care of newborns since World War II, and declines in both the mortality 
rate and the frequency of informed autopsy study, militate against there being another 
opportunity for similar data to be obtained. It is noteworthy, accordingly, to see several 
presumed or intuitively considered aspects to be confirmed by the archive. The role of thyroid 
factors was well assessed by Redding and Pereira (1974) whose earlier work was in part a 
stimulus for these studies (Redding, et al., 1969; Redding, et al, 1972). Those reports considered 
thyroid factors as a feature of maturation of the pulmonary surfactant system but did not infer a 
pathogenetic role of the thyroid in hyaline membrane disease. However, with a considerable 
number of cases in the Archive, viewed in retrograde fashion, 1965 back to 1955, a period prior 
to "modem" measures of clinical support and treatment beyond those of the 1930s and 1940s, 
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of the developing thyroid gland, as more colloid accumulates, there will be fewer cells in each 
milligram of tissue. But to take this to a deeper level, it should be noted the number of specific 
nuclear T 3 receptors in the lung, as the peripheral action site for thyroid effects on lung, varies in 
the rabbit. Lindenberg, et al., (1978) found 2400 specific binding sites per pulmonary cell in the 
fetus contrasted to 1120 sites per adult lung cell. Thus, size or size ratios have to be considered 
as an indirect marker for functional capacity as a rule, but when the data base is large and the 
trend is consistent in one direction, then greater weight may be placed on the result. 
The archival wllection of 450 newborns, 154 with hyaline membrane disease, has an utterly 
consistent pattern of small thyroids from midgestation to term. These cases had highly varied 
survival times but subgroup coherence is shown in the mean crown-heel and crown-rump 
lengths. Fetal body length is a better index of gestational age and maturity than birth weight and 
it seemed well advised to determine whether an immediate post natal loss of thyroid mass had 
occurred as it seemed unlikely such a definitive ratio could be maintained in the awareness that 
average post natal survival differs considerably over gestational time, those near midgestation 
surviving just a few hours as an upper limit (Shanklin and Zhang, 2007). A return to the Potter 
Archive in early 2011 resulted in the information found in Tables 2, 4, and 5, and Figures 2 and 
3.on the average. This study yielded information on the thyroid:body mass ratio in the first hours 
after birth. 
There is virtually no information on this point with a singular exception. Little (1991) 
considered the effect on newborn pups of the southern elephant seal of being born into the 
almost freezing environment of Macquarie Island in far South Pacific ocean. He concluded there 
was little effect overall up to 50 hours after birth but when the results were plotted by time after 
birth there appeared a distinctive ~2% drop in thyroid mass in the first two hours and a 3% 
increase in thyroid epithelial height height which later displayed a 24.5% loss of vertical 
dimension (data not shown). Thyroid mass increased after about 120 hours post natal. There 
are important differences, of course, between newborn rabbits in an experimental setting in a 
heated incubator and elephant seal pups in their native habitat with considerable reserves of 
adipose tissue. In the seal pup T4 peaked at two hours and T3 at four days (Little, 1991 ). 
The second phase of archival review is also a unique dataset, for the same reasons noted above. 
Figure 3 shows the biphasic decline in the thyroid:body mass ratio. The question arises whether 
the 30.9% decline from birth to 12 hours plus a subsequent decline to a final reduction of68.2% 
at 66 hours after. birth accounts for the remarkable difference seen in Table 1 and Figure I. The 
numbers themselves bracket the range of ratios found in the first phase review. The data was 
drawn from the two reviews under a different rubric and, although the body weight is 
progressive over gestational time, it is a secondary variable (Fig. 8). Some insight into this 
comes from Figure 10. This takes the paired mean body weights by gestational age range and 
converts them to a weight ratio. The earliest gestational period, 22-27 weeks, has a ratio of 
1.104 which rapidly declines with the passage of time. The same calculation of the thyroid 
weights as an HMD/control ratio yields an inegular series: 0.736, 0.750, 0.723, 0.603, 0.695, for 
the intervals 22-27, 28-30, 31-33, 34-36, and 37-39 weeks respectively (data not shown 
graphically). These non-linear relationships, all being less than the body weight ratios across 
the same time frame, are evidence against mass loss of the thyroid post natal over gestational 
time as the sole or a major controlling factor operant in Figure 3. The inference is while there is 
a tendency toward smaller fetuses the thyroids become disproportionately even smaller. The 
critical message of the analysis which was drawn from 4,588 autopsy records is that the control 
cases did not show this effect at all. Accordingly, there is some intrinsic aspect of the thyroid 
gland or of the thyroid arena in the pathophysiological or developmental sense which gives rise 
to these evident abnormalities of time resultant thyroid size. 
Progressive weight loss of the experimental animal from birth to surgery and after vagotomy or 
other procedures, is evidence of a metabolic effect at work in the model. Table 1 provides mean 
birth weights by gestational age ranges for hyaline membrane cases and control newborns. The 
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ratio of these mean weights is plotted in Figure I 0, the weight of HMD cases as the antecedent 
value and the control cases as the consequent variable. Only in the first time set does the ratio 
exceed 1.00 and afterwards it declines to around 85% (15% loss) at 32 weeks, remaining there 
for the remainder of gestational time. 
The clinical study: 
There have been many reports on studies of thyroid function in both healthy and distressed 
newborns and premature newborns (Carrascosa, et al., 2004; Clemente, et al, 2007; Cuestas and 
Engel, 1979; Delange, et al., 1984; LaFranchi, 1999; Redding and Pereira, 1974; van 
Wassenaer, et al, 1997; Williams, et al., 2005). The earliest of these is that of Redding and 
Pereira (1974). In some respects this is similar to the study report here. It is larger but TSH was 
not determined, but included normal full term infants as a collateral control, a feature absent 
from the present study. Redding and Pereira reported 79 premature infants, 40 with RDS and 39 
without. The mean cord blood T4 in RDS infants was 7.2 ± 1.4 IJ.g/dl against the control value 
of 8.5 ± 1.3 llg/dl, the former 15.3% less than the latter. Remarkably, although the results here 
are slightly lower, the difference [Table 7a] is almost exactly the same, 15.6%. Moreover, they 
reported progressive values. Premature infants with RDS at less than 29 weeks= 5.6 ± 1.2, 30-
33 weeks= 7.2 ± 1.4 (the same as whole group mean), and at 34-37 weeks= 7.9 ± 1.1 ~J.gldl. The 
controls were all above 29 weeks but also showed progression: 8.5 ± 1.3 at 30-33 weeks, and 9.0 
± 1.9 ~J.g/dl at 34-37 weeks. The differences were all significant at either p<O.OS or <O.Ol. 
Cuestas and Engel (1979) reported a lower mean TSH peak in the RDS group (32.8 ± 9.6 ~J.U/ml) 
than the controls (60.9 ± 21.8 IJ.g/dl), with p <0.005. The RDS value was 53% of normal. 
Williams, et al. (2005) recruited 780 infants at a gestational age of 23-24 weeks and followed 
them for 28 days post natal. They correlated thyroid factor values with most of the ills which 
afflict extremely premature infants. There was a positive correlation between low TSH and 
oxygen dependence at 28 days. 
Alone of the eight papers cited here, Redding and Pereira (1974) reported the Apgar Scores of 
both subsets. They reported the scores in a different format, the frequency of those less than 6: 
26/40 intants with RDS (65.0%) and 12/39 controls (30.8%). Moreover, only three other than 
Redding and Pereira reported cord blood values as point of birth determinations (Carrascosa, et 
al., 2004; Clemente, et al., 2007; van Wassenaer, et al., 1997). These are confirmatory and 
appear to establish low thyroid function amongst the causal factors on a time sequence basis if 
for no other reawn. 
Animal experiments: prevagotomy thyroxine: 
The effect ofprevagotomy thyroxine (T4) is shown in Figures 4, 5, 9, and 12, and in Tables 8 and 
9. Figure 4 demonstrates an early positive effect on survival, considerable shortening of Phase 
A and about a 20% extension of Phase B ( 42.85 hours versus 34.29). However, final Phase C 
has a sharper onset and a steep decline to zero survival for a maximum just 75% of the air only 
controls. This qualifies as a hormetic effect, essentially, albeit spread over a time dynamic rather 
than as a dose response curve (Calabrese and Baldwin, 2001; Robertson and Grutsch, 1987). 
That thyroxine is having a specific pulmonary effect, as well as the probable influence on 
metabolism, is shown in Figures 5, 9, and 12. Figure 5 is a 2-dimensional plot of mean gross 
lung injury against the log 10 of the dose applied at 3 hours of age, 21 hours before vagotomy 
which clearly shows the exponential relationship, implying a possible primary forcing role to T4 
when added as a pharmacological substance over a three point grid beyond the physiological 
range of newborn rabbits. Figure 12 is a 3-dimensional plot which combines the log 10 dose, the 
mean gross lung change, and mean survival for each dose level. The third factor smooths out 
the very small difference in values found from the initial linear regression seen in Figure 5 and 
provides an even clearer picture of the forcing effect of thyroxine on the lung experiencing 
respiratory distress, although paradoxically there is a reduced worsening as the dose is increased. 
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This is not a contradiction of the positive influence of thyroid factors on surfactant function in 
the neonatal lung since that is an effect of nuclear triiodothyronine (T 3) receptors in the lung (Luo, et al., 1989). The result implies an excess ofT4 which might have been circulating as free 
thyroxine (the index, FTI) thus being available for a specific dynamic effect which in this 
experimental model is enhanced lung injury. Against this explanation is a lower FTI in 
RDS/HMD cases [Table 11] which was also found by Redding and Pereira (1974): infants with 
RDS, 1.99 ± 0.30; controls, 2.54 ± 0.18, a significant difference with p<O.Ol. Since serum 
protein [Table 7b], including thyroid binding globulin, was significantly lower in the RDS/HMD 
subset (4.05 ± 0.21 g/dl) compared to the controls ( 4.69 ± 0.18 g/dl) there might have been less 
binding capacity. Not reported in Tables 7a or 7b were determinations of thyroid binding 
globulin specifically. The RDS/HMD subset had 17.408 ± 1.490 J..lg/dl and the controls 19.857 ± 
0.761 ~tg/dl; this small difference approached significance with p = 0.0698 [Table 11]. 
The other side of the equation is whether a reduction in carrying capacity results in a higher free 
thyroxine index (FTI). Table 11 shows it did not clinically. The difference between RDS/HMD 
cases and the controls, 0.612, is even less significant, with p = 0.1760. The lower FTI in the 
larger series reported by Redding and Pereira (1974) was significant and had a difference of a 
similar order of magnitude of 0.55. Just why their range of FTI values is so different is not 
known but may be related to the method of calculation of the index. Redding and Pereira (197 4) 
used the formula: FTI = T4/%T3• Brien, et al. (1974), who reported values in the same range (7.5-
18.0) as in the current study, used the formula: FTI = T4/T3, as was done here. 
Nevertheless, the lung injury in these experimental animals cannot be explained on the basis of 
the binding capacity of serum proteins, whether specific or nonspecific. The difference in 
thyroid binding globulin is insufficient to account for the pulmonary effect which has an 
ascending if complex quantitative ;response to dose applied. Although their paper does not 
provide the number of animals per determination, Myant and Osorio (1959) reported total serum 
protein in rabbit fetus and on the day of birth as 4.446 g/dl (301h day of gestation), 4.598 g/dl (31'1 
day). and 4.598 g/dl for the first postnatal day, values well within the range found in the clinical 
arm of this study. 
The present report contains no information on thyroxine receptors (TR). Keijzer, et al. (2007), 
using mRNA and protein analysis found TRa2 to occur first in developing rat lung, followed by 
TR~L but no TR~2 in either form. TRal protein was identified in lung but its mRNA was not. 
Keijzer, et al. (2007) found the mRNA for TRa alpha was ten times as high as in the liver but in 
brain it was 100 times the hepatic concentration. They concluded there was extensive post-
transcriptional regulation which varies according to the organ or tissue. This is congruent with 
the current finding that lung injury is produced by thyroxine across a pharmacological range in a 
reverse exponential fashion (i.e., higher doses result in more injury but on a progressively 
diminishing scale). Thyroxine thus has no potential role in the clinical management of 
respiratory distress syndrome. This same conclusion was reached by Stahnke, et al. (1986), but 
on very different grounds from a study of clinical laboratory data on RDS newborns. 
Animal experiments: prevagotomy thyrotropin: 
The effect of thyrotropin is shown in Tables 8 and 9 and in Figures 4 and 6. Figure 4 conveys 
what might have been anticipated, a delay in the trophic effect, a doubling of the length of the 
curve in Phase A, a substantial increase in Phase B, 1.45 times that following thyroxine and 1.8 
times that of the air only controls, and a terminal slope in Phase C intermediate to both of the 
others. Despite these aspects, the fact they occur after considerable mortality has passed is the 
explanation tor the overall shorter mean survival shown in Table 8, just over 15 hours against 
almost 20 for thyroxine, actually 75.7% of the latter. Both mean survivals greatly exceed that 
for the air only controls at 6.87%. The median survival for TSH treated animals is 40% higher 
than the controls but botl1 are under five hours. The area under the survival curve is essentially 
the same for post thyroxine and post thyrotropin animals. This can be taken as evidence of a net 
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common effect on the thyroid arena, by thyroxine directly, and by thyrotropin through its usual 
channels, viz, the trophic process. These comparative distinctions are summarized as regression 
slopes in lhe far right column of Table 9. 
From this point the data develop a compelling complexity. Figure 6 has a very different aspect 
of the thyrotropin effect. When gross lung change is plotted against the log10 of the dose of 
thyrotropin the U-shape of hormesis (Calabrese and Baldwin, 200 I; Robertson and Grutsch, 
1987), with a low dose range shoulder, appears. Remarkably, it appears the system of thyroid 
stimulations and peripheral actions, possibly including nonthyroida1 conversion of T4 to T3, is 
least disturbed by a dose of I 0 mU/kg thyrotropin. Perhaps even more remarkable is the close 
approximation of quantitative gross lung change at all three of the other doses, 0.1, 1.0, and I 00 
mU/kg. When independently plotted, linear regression yields a mean which fully brackets all 
three data points within one standard error of the mean (SEM). This seems to violate 
biochemically one known attribute of thyrotropin effect, the stimulation of cAMP 
phosphoinositide signaling (Boutin, et a!, 20 11 ). The current data set does not provide 
information on the presence of or the relative activity of low or high affinity thyrotropin binding 
sites, either in the thyroid (Lefort, et al., I 984) or elsewhere (Ishigaki, et al., 1989). Lefort, eta!. 
(I 984) concluded that low affinity sites do not participate in the stimulation of adenylate cyclase. 
Nor is TSH likely to be active in peripheral organs which convert T4 to T3• Hepatic and renal 
deiodinases are very active, accounting for perhaps 80% of the peripheral conversion 
(Hillgattner and Romsos, 1987), although it has been suggested the renal activity is directed at 
least in part toward the excretion of iodides by further deiodination ofT 3 (Shimoda and Greer, 
I 972). The population of TSH receptors outside of the thyroid gland is limited and liver 
appears to have few if any (Endo, et a!., I 993) while kidney does (Dutton, et al., 1997). TSH 
receptors have been identified in the anterior pituitary (Theodoropoulou, et al, 2000) offering the 
, possibility of a feedback loop through thyrotropin-releasing hormone. Rates of conversion have 
been reported in slices of human tissue, kidney, liver, heart, and skeletal muscle (Albright and 
Larson, 1959). Only kidney of these four showed measurable conversion, averaging 22.30 ± 
2.84 per cent (N = 1 0). 
Animal experiments: early neonatal thyroidectomy: 
The experimental results are entirely summarized in Figure 7 and Table I 0. There is a 
continuum along the survival curve for animals whether treated after surgery to an environment 
of air or 100% oxygen. The principal finding related to the distribution of survival along the 
continuum. lwice as many oxygen treated animals survived past 48 hours, and no oxygen 
treated animal died before 48 hours [Table I 0]. This is a classic X2 scenario with a highly 
significant result, p = 0.0073. There was a strong trend in the results of gross lung injury as 
noted above, a mean in oxygen twice that in air, but the small samples did not yield the standard 
p threshold of0.05. 
Antenatal thyroidectomy in the lamb followed immediately by delivery failed to change the T4 
levels at 60 minutes after birth but there was a much lower value T3, after fetal thyroidectomy, 
39.0 ± 4.8 ng/dl, versus 153.0 ± 20. I in shan1 operated fetal lambs (Polk, et al., 1986). Follow 
up study revealed no change in 5'-monodeiodinase for any tissue from either sham or late fetal 
thyroidectomized subjects. Polk, eta! (I 986) concluded the post natal surge in T3 came from the 
thyroid and not from peripheral sources. In the present work thyroidectomy was timed to get 
past the surge at two hours post natal, allowing for that immediate effect to have occurred prior 
to environmental challenge. One cannot assess how much of a factor this might have been 
relative to the late fetal procedure used by Polk, et a!. (1986) as it was not part of the current 
protocol. The previously mentioned report of Nagao, et al (2011) invoked the reinfusion of T4 
from storage status elsewhere, from possible enterohepatic recirculation following excretion in 
bile, or from extrathyroidal production. Either of the first two might be applicable given the 
similarity of time frames in the current study and theirs. Nagao, et al. (201 1) offered no data to 
support the third suggestion. 
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Concluding comments: 
The difficulties in sorting out the effects of thyTOid arena hormones, from thyrotropin-release 
hormone, through TSH, and in the peripheral conversion of T4, have been long known. In one 
sense this is the profound dilemma of intact animal investigation, those forces regularly applied 
to maintain homeostasis, whilst disturbed by the experiments, may play a necessary role in the 
process. By combining historical data, from what might advisedly be called near to natural 
conditions, but no longer available concurrently or prospectively, with more up to date clinical 
assessments and animal experiments, some idea of the pathogenesis has been drawn together if 
for no other reason than to rule out certain aspects, such as a possible beneficial role for 
thyroxine in lung injury, leaving a field for future consideration less cluttered than presently. 
The more modem cellular techniques, however, would need to be applied to an animal model 
and although much has been learned from neonatal rabbits a larger research animal with a longer 
gestation would enable study of the rather early gestational period suggested here as the time 
when the pathogenesis gets underway. 
This period has been the subject of increasing interest. The importance of TSH to the early 
pathogenesis of hyaline membrane disease is highlighted by two aspects. First, the a-subunit of 
TSH and hCG are identical (Garcia-Campayo, et al., 2002; Norman, et al., 1987) and hCG has 
been acknowledged as a weak thyrotropin despite the differences in the P-subunit (Hershman, 
1999). Although weaker in molar effect, the considerable increase in levels of hCG in the four 
week periods, 9-12 and 13-16, to maximum levels of288,000 and 254,000 miU/mL respectively 
(McPherson and Pincus, 2006) offers the possibility of a thyrotrophic effect secondary to hCG as 
an additive stimulus to the expected changes in formulation and maturation of the hypophyseal-
pituitary-thyroid stimulating processes in the first half of the second trimester. Second, there is 
evidence of a relationship between the level ofhCG and intrauterine growth retardation (Haddad, 
et al., 1999; Hagan, et al., 2004; Liu, et al., 1999; Onderglu and Kabuk<;:u, 1997; Vaillant, et al., 
1996) although there is some question whether very early low values (Haddad, et al., 1999) or 
elevated values around the end of the first trimester or in the early second trimester is the 
important finding (IIagan, et al., 2004; Liu, et al., 1999; Onderglu and Kabuk<;:u, 1997; Vaillant, 
et al., 1996). There is no other reported link similar to the data in this report. It may be the 
factor which distinguishes those fetuses which later will be underweight relative to their 
gestation [Table 1, Figure 1] and have hyaline membrane disease is some form of integrated 
interaction between placental hCG and fetal TSH-releasing hormone, TSH, and the modulating 
effects offetal thyroid activity. 
This paper concerns major aspects of the metabolic adaptations of newborns. The basic 
metabolic transformation which follows birth is a reversal of the dominant principal fetal energy 
food source. Prenatally, the nutrient supply is rich in carbohydrates and low in lipids with both 
gluconeogenesis and ketogenesis absent to low. Postnatally these factors are reversed and 
gluconeogenesis increases toward adult levels soon after birth and a rate limiting enzyme, 
phosphoenolpyruvate carboxykinase (PEPCK) emerges and becomes significant (Girard, 1990). 
However, in this vagotomy model, the transition is delayed in part by the non-provision of the 
programmed postnatal nutrients. Although the metabolic factors discussed herein, especially 
thyroxine, are integral to the maturation, production, and release of pulmonary surfactant, that 
aspect of the scheme will be reported elsewhere. 
Of interest quantitatively, with the more or less consistent half size of the thyroid and adrenal 
across gestational time (Table 1 and Figure 1), is the observation that total carbohydrate reserves 
in infants dying from hyaline membrane disease are about half those found in other neonatal 
deaths (Shelley, 1964). The juxtaposition of these findings is evidence of a deeper metabolic 
factor, likely progressing through gestation and marking the special subset also seen here in the 
clinical data. The latency of the absolute and relative weights for the adrenals can be taken as 
evidence of a more primary or necessary role for the thyroid arena. 
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Detailed examination of the role of the adrenal gland and cortical hormones were not undertaken 
here but some aspects of the interrelation between thyroid factors and adrenal factors with the 
pulmonary surfactant system have been reported (Ohashi, et al., 1991; Rooney, et al., 1986). 
Other factors, some with neurovascular actions, such as aminophyllin, have been found to 
enhance surfactant production (Sevanian, et al., 1979). 
But there is another aspect. Genetic mutations in the TSH-receptor gene have been implicated in 
both congenital hypothyroidism (Bretones, et al., 2001) and in congenital hyperthyroidism 
(Chester, et al., 2008). The genetic factors presumably involved in alleles of receptors can be 
addressed indirectly by deeper analysis of maternal, paternal, and litter effects in the research 
database from which these specific experiments were drawn. This will be reported elsewhere in 
the context of an overall assessment of the neonatal rabbit model. 
A new and unique perspective on this is that of Pei, et al. (2011). Knock-in mutations of the 
nuclear co-repressor SMRT (silencing mediator of retinoid and thyroid hormone receptors) in 
C57BL/6 mice produced a previously identified respiratory distress syndrome caused by 
prematurity of type I pneumocytes, the principal peripheral lung epithelium most responsible for 
oxygen, carbon dioxide, and water exchange between the peripheral air spaces and the intrinsic 
tissue of the lung. 
The demonstration of a stimulatory effect of IL-2 on pituitary cells, including thyrotropes, has 
not been well developed following the original report (Artz, et al., 1995); theirs is not an isolated 
observation. Collateral evidence comes from instances of hyperthyroidism (Koukkou, et al., 
1995) and the observation that therapeutic use of recombinant IL-2 in renal cell carcinoma leads 
to thyroid dysfunction including transient hyperthyroidism (Jacobs, et al., 1991 ). Thus, another 
trophic layer is added to the thyroid arena when TSH-releasing hormone is taken into account 
(Guillaume, et al., 1985). There are no comparable studies as yet during pregnancy in either 
humans or experimental animals. Whilst these and potentially other considerations may be 
found to operate within the developing thyroid arena, one fact remains very clear from the 
archival analysis: the control cases do not show these several effects at all. Therefore there is an 
intrinsic aspect of thyroid gland development behind the pathophysiological abnormalities and of 
thyroid size which causes or promotes the respiratory distress syndrome and hyaline membrane 
disease. The evidence across gestational time strongly suggests the inference the point of origin 
lies in the early to mid-second trimester when chorionic gonadotropin is still ascendant and TSH 
rises dramatically, pushing the fetal thyroid gland to it maximal relative weight. 
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Legends 
Table 1: 
Archive tally of 450 newborns from the decade 1955-1965, with size of subsets, 
proportion of males, mean usual measurements (body weight, crown-heel length, and 
crown rump length) with mean weights of thyroid and both adrenals from 154 neonatal 
autopsies with hyaline membrane disease and 296 others, excluding gross malformations 
and known syndromes. 
Table 2: 
Year by year inventory of 4,588 microfiche autopsy records in the Potter Archive with 
data breakdown by classification categories as to source, stillbirth or livebirth, and net 
cases fit for review. 
Table 3: 
The pattern of divergence from normal of the adrenal glands is delayed or latent, shown 
here as the difference in their weight from normal and the significance by t test. A 
significant difference appears after 28 weeks, whilst that for the thyroid occurs 4-5 
weeks earlier. 
Table 4: 
Ascertainment of the prevalence of hyaline membrane disease, 1934-1942, in the three 
Chicago Lying-In Hospital services and from the 53 outside cases in the Bundesen-Potter 
study. The CLIH services had twice the prevalence overall in their premature newborns. 
Table 5: 
The progression of the prevalence of hyaline membrane disease 1934-1942 differed 
between the CLIH services and outside hospitals from year to year, approximating a 
three-fold difference in 1940-1942. 
Table 6: 
Apgar Scores at birth in the clinical study of 1972, 24-28 weeks gestational age. 
Tables 7a and 7b: 
Laboratory data obtained from the clinical study of 26 premature newborns. 
Table 8: 
Characteristics of newborn rabbit survival after bilateral cervical vagotomy either in air 
only controls or with thyroxine or thyrotropin at age 3 hours. 
Table 9: 
Comparative means and regression slopes of phases A, B, and C, with especial details 
referent the thyroxine series. 
Table 10: 
The significance of survival after thyroidectomy by exposure to oxygen or air. X2 = 7.204, 
p = 0.0073. 
Table 11: 
Thyroxine carrying capacity of serum proteins. 
Legends 
Figure 1. 
Normalized weights of thyroid and both adrenals from 450 neonatal autopsies, 154 with 
hyaline membrane disease and 296 others, excluding gross malformations and known 
syndromes, plotted by midpoints of three week gestational ranges. The values for both 
glands in all subsets track each other closely throughout the third trimester, with HMD 
values approximately half those of the control cases. From the Potter Archive 1950-
1965. Of possible interest is the observation that normalized HMD adrenal weights are 
slightly higher than the thyroid which is the reverse of the control group after 30 weeks. 
Figure 2. 
Annual prevalence of hyaline membrane disease is the earliest part of the Archive which 
shows the beginning of diagnosed HMD and a sharp rise in the prevalence at Chicago 
Lying-In Hospital with its two affiliated services contrasted to the other 53 institutions 
under the Bundesen Plan. The change coordinates closely with the introduction into 
premature neonatal care of the Hess Oxygen Bed. 
Figure 3. 
Thyroid: body weight ratios by duration of post natal survival in 50 cases from the earliest 
years of the Archive, 1934-1942, a period of typically minimalist treatment of the 
premature newborn. The ratio is thyroid weight in milligrams divided by autopsy weight 
in grams. The secondary decline from 12 to 66 hours post natal has a regression equation: 
Ratio= -.00000650629 (survival in hours)+ 0.000683954 (by least squares analysis). By 
contrast, thyroids of 1 00 contemporaneous control cases showed no decline in the ratio 
for up to ten days post natal (data not shown). 
Figure 4. 
Semi-log10 plot of survival of 225 newborn rabbits after bilateral cervical vagotomy: 36 
after pre-BCV thyroxine at age 3 hours, 63 after pre-BCV thyrotropin at 3 hours, and 126 
air controls after BCV only. The control curve shows the typical result of such 
experiments, a sharp loss of animals by 10 hours post-BCV (Phase A), an extended Phase 
B to about 45 hours, and an accelerated final Phase C. By contrast thyroxine 
pretreatment greatly shortened Phase A with a similar length of Phase B and a sharper 
final Phase C. The thyrotropin effect on Phase A was along the control plot until about 
4 hours when an extremely protracted Phase B set in , about twice as long as that of 
either of the two other subsets, and then a moderately sharp final Phase C. These 
survival plots are conguent with the interpretation of Shanklin and Sotelo-Avila (1967) 
which concluded Phase A was likely the result of partial laryngeal constriction because 
bilateral cervical vagotomy also interrupts the recurrent larnygeal nerve. From this, then, 
thyroxine and thyrotropin may act against the loss of that motor nerve action but the 
mode or manner of this remains unknown. 
Figure 5. 
The extent of pulmonary injury in the thyroxine subset was exponentially proportionate 
to the log10 dose of thyroxine. The same relationship held true for the degree of change in 
Phases A and B( data not shown) and this fact drives the result for the whole series shown 
here. The regression equation is: Mean gross lung change= 6.05 (log 10 dose) + 15.6439. 
Figure 6. 
The extent of pulmonary injury in the thyrotropin subset differed considerably from the 
thyroxine subset. This plot of mean gross lung change against the log10 dose of 
thyrotropin shows no difference when the dose was 0.1, 1.0 or 100 mU/kg and a 
regression analysis of these three subsets resulted in a flat line with a slope of zero. By 
contrast the dose of 10 mU/kg significantly reduced the extent of lung injury. 
Thyrotropin has systemic effects beyond its influence over thyroxine secretion by the 
thyroid but whether its prime function or some aspects of its secondary roles results in 
what gives the appearance of a "protective" role or is simply that dose least disruptive of 
TSH homeostasis which is not shown in the data as derived by this experiment. Note that 
all three other mean results fall within one standard error the subset mean. 
Figure 7. 
The effect of thyroidectomy at two hours post natal required a different mode of graphic 
analysis. This plot gives the survival post thyroidectomy. Eight of20 newborn rabbits 
were placed in 1 00% oxygen and these were followed until demise along with ten left in 
air. Remarkably, 60% of those in air died before 48 hours post surgery but all eight in 
oxygen survived beyond 48 hours. Two animals were subjected to BCV at the usual age 
of24 hours (22 hours post thyroidectomy) and left in air for their entire survival interval. 
Remarkably, one died at 0.95 hour post-BCV and the other at 1.02 hours post-BCV, and 
both had gross lung change at the 52% level, remarkably quick lesion formation 
compared to BCV controls. The survival difference without BCV between oxygen and 
air runs is very highly significant by ·x_Z, with a p value of >0.0001 despite a Student's t 
test= 1.63938, p = 0.0603. 
Figure 8. 
Ratio of thyroid weight to body weight by gestational age. The ratio rose at a slightly 
increased rate from 12-13 weeks, at which time the ability of thyroid to concentrate 
iodine begins. There is then a progressive rise in the ratio to midgestation under the 
influence of rising fetal TSH which peaks around 25 weeks, about one month after the 
ratio becomes maximal. There is little change during the later part of the second 
trimester to 30 weeks, after which somatic growth becomes more marked, resulting in a 
decline in the ratio (Adapted from Shanklin, 1991 ). 
Figure 9. 
Effect of pre-BCV thyroxine on body weight loss following vagotomy. The control 
animals lost about 25% of body mass by 75 hours post-BCV and the thyroxine group 
tracked the same rate up to 35 hours after which there was marked acceleration of weight 
loss, 28% by 50 hours. The light lines around the heavy mean regression line are the 
individual subset weight losses, a fairly tight and consistent result. There was no evident 
effect on the ratio of surgical weight to birth weight in any subgroup, including the 
controls (data not shown). 
Figure 10. 
When the birth weights ofthe HMD and the non-HMD subsets (Table I) are directly 
compared as a ratio there is a dramatic fall in the ratio from 24.5 to 32 weeks gestational 
age and an effectively constant relationship thereafter. Thus, premature newborns lose 
15% of their relative thyroid weight by 32 weeks. 
Figure 11. 
Samples of the variation in thyroid histopathology during gestational ages 18.5 to 36 weeks. 
A. Image obtained by scanning original H&E cross section of the cervical tissues. Estimated 
gestation 31-33 weeks, birth weight= 2010 g, Nonmacerated antepartum fetal death from 
massive abruption of the placenta. Monochorionic, diamniotic twin #I, parabiotic 
recipient with enlarged thyroid gland, about twice normal volume, mildly hyperactive. 
Mild maternal gestosis. Lung showed extensive, deep aspiration of amniotic content. 
B. Image obtained by scanning original H&E cross section of the cervical tissues. Gestational 
age 33 weeks, birth weight 2249 g. Liveborn survived 9 hours, poor color and muscle 
tone, tachycardia and tachypnea. Clinical diagnosis of pneumonia treated with 
ampicillin/gentamicin. Failed to respond to these and general supportive measures. 
Autopsy revealed congestive heart failure with diffuse myocardial necrosis. Thyroid 15X 
normal size with diffuse hypersecretory state (toxic congenital goiter), much more active 
than Figure IIA. The clarity of the thyroid epithelium is apparent even at this 
magnification. 
C. H&E. Original magnification, 1 OOX. 18.5 weeks, birth weight 223 g, survived 4 hours, despite 
no active resustitation. Intrauterine diagnosis of Klinefelter syndrome confirmed with 
chromosome analysis, XXY and numerous Barr bodies. Autopsy revealed extreme 
somatic and pulmonary immaturity, the latter in the organoid phase. Scattered thyroid 
follicles witl1 scant colloid accumulation against a generally an immature prefollicular 
gland. 
D. H&E. Original magnification, 1 OOX. 36 weeks, birth weight 2170 g. Survived 55 minutes; no 
air could be put into the lung due to extensive tracheal atresia, a 5.2 em missing segment; 
some air possible by needle placement in lower trachea. Autopsy also revealed cleft 
common upper trachea and esophagus, post ampullary duodenal atresia, and lower facial 
bony anomalies on a square head. The thyroid was moderately enlarged with 
disseminated hyperactivity as shown by the circumferential vacuoles at the colloid:lining 
cell interfaces. 
E. H&E. Original magnification lOOX. 33 weeks, birth weight 1450 g. Survived 30 hours. 
Osteogenesis imperfecta congenita. Obvious blue sclerae. Partial premature closure of 
foramen ovale, bilateral cardiac hypertrophy. Abundant indolent colloid in thyroid 
follicles, many of which are over distended. 
Figure 12: 
Three-dimensional plot of thyroxine dose, survival in hours, and extent of gross lung 
injury for each of the three dose levels. The connecting line is precisely linear, strongly 
indicative of a forcing effect of thyroxine. 
Tables 
Table 1: Differential thyroid and adrenal weights: newborns both with and without hyaline 
membrane disease. 
Gestation Number of Males Mean body Mean CH Mean CR Mean Mean 
(weeks) cases (%) weight (g) length (em) length (em) thyroid adrenal 
weight (g) weight (g) 
22-27 71 non-HMD 40.6 886 ± 47 34.0 ± 0.4 23.0 ± 0.4 0.76± 0.04 3.7±0.33 
28HMD 60.7 978 ± 13 36.0 ± 0.6 24.0± 0.4 0.56 ± 0.05 3.6±0.19 
28-30 50non-HMD 40.0 1192± 70 38.0 ± 0.5 26.0± 0.4 0.84± 0.05 5.0± 0.32 
32HMD 50.0 1183±75 38.0 ± 0.7 26.0 ± 0.7 0.63 ± 0.04 4.0± 0.24 
31-33 50non-HMD 42.0 1884 ± 123 42.0 ± 0.8 29 0± 0.7 1.01 ± 0.09 5.7 ± 0.25 
48HMD 60.2 1586 ± 45 42.0 ± 0.5 29.0± 0.4 0.73 ± 0.03 4.5 ± 0.18 
34-36 44 non-llMD 46.0 2267 ± 88 45.0 ± 0.8 31.0±0.4 1.36 ± 0.11 7.5 ± 0.55 
18HMD 55.5 1954± 103 44.0±0.7 31.0±0.5 0.82 ± 0.06 5.4 ± 0.44 
37-39 81 non-HMD 55.5 2706± 96 49.0 ± 0.4 34.0 ± 0.3 1.41 ± 0.08 8.4± 0.60 
28HMD 67.8 2248 ± 91 47.0 ± 0.6 32.0 ± 0.8 0.98 ± 0.07 5.8 ± 0.33 
Data as means ± SEM 
Table 2: Record by record inventory of CLIH perinatal autopsy archive: 
Year 1934 1935 1936 1937 1938 1939 1940 1941 1942 Total 
Total 46 162 262 602 830 630 731 667 658 4588 
Outside cases 0 6 91 405 589 425 451 436 424 2827 
No record 0 6 3 6 6 9 20 25 19 94 
No lung slide 0 0 0 54 7 8 7 12 12 100 
Pediatric age+ 0 0 7 57 96 92 72 71 82 477 
Placenta only 0 0 0 0 0 0 2 0 0 2 
Net for review 0 0 81 288 480 316 350 328 311 2154 
Stillborn 0 0 61 170 278 209 237 232 201 1388 
Newborn 0 0 20 118 202 107 113 96 110 766 
HMDIVC 0 0 1 11 8 9 10 12 8 59 
Percentage 0.00 0.00 5.00 9.32 3.96 8.41 8.85 12.5 7.27 7.70 
Main sequence 46 155 171 197 235 205 280 231 231 1751 
No record 1 0 1 1 0 0 0 0 4 7 
No lung slide 6 3 3 3 0 1 2 3 6 27 
Net for review 39 152 167 193 235 204 278 228 221 1717 
Stillborn 29 107 125 137 153 143 199 168 145 1206 
CLIH 9 84 79 88 96 80 123 104 99 762 
Home Service 4 8 12 7 8 5 18 6 6 74 
CMC 16 15 34 42 49 58 58 58 40 370 
Newborns 10 45 40 56 82 61 79 60 76 509 
CLIH 8 36 26 43 44 49 64 45 53 368 
Home Service 1 4 10 5 5 2 4 1 5 37 
Table 3. Delayed divergence of adrenal weights in hyaline membrane disease. 
Ditlerence Degrees of 
Gestational range in weight freedom t p 
22-27 weeks 0.1 g 97 0.2632 0.3965 
28-30 1.0 80 2.5000 0.0072 
31-33 1.2 96 3.895 0.0001 
34-36 2.1 60 2.982 0.0021 
37-39 2.6 107 3.797 0.0001 
Table 4. Overview of autopsy cases in the Potter Archive. 
Category Outside services CLIH services 
Total autopsies 2827 1751 
Net for review 2154 (76.17%) 1717 (98.06%) 
Stillborn 1388 (64.44%) 1206 (70.24%) 
Newborn 766 (35.6%) 509 (29.76%) 
Hyaline membrane 
disease 59 77 
PercentHMD 7.70 15.13 
Table 5. Year by year accession of cases ofRDSIHMD, 1934-1942. 
Source 1934 1935 1936 1937 1938 1939 1940 1941 1942 Total 
Outside 
RDSIHMD 0 0 1 11 8 9 10 12 8 59 
Per cent 0.0 0.0 5.0 9.32 3.96 8.41 8.85 12.5 7.27 7.70 
CLlli 0 2 2 8 1 6 19 21 18 77 
RDSIHMD 
Percent 0.0 4.45 5.0 14.3 1.22 9.84 24.0 35.0 23.7 15.13 
Table 6: Apgar scores at birth, 24-38 weeks gestational age. 
Subset Number Apgar range Mean Apgar Score 
Control-normal 
Control-normal 14 3-10 8.21 ± 0.48 
RDS/HMD 12 2-9 5.33 ± 0.58 
t = 3.845, p = 0.0004 
Table 7a: Mean birth weight, serum T4 , and serum TSH. 
Subset Number Gestational Mean Birth Mean T4 Mean TSH 
Range (weeks) Weight (grams) J.lg/dl J.!IU/ml 
Normal 14 28-38 2020.79 ± 93.54 7.58 ± 0.45 10.91 ± 0.76 
Controls 
RDS/HMD 12 24-37 1693.83 ± 143.64 6.40 ± 0.49 9.87 ± 1.03 
Difference p = 0.0309 p = 0.0455 p = 0.2125 
Table 7b: Total serum protein values. 
Subset Number Range of protein as Mean serum protein 
g/dl as g/dl 
Normal 14 3.70-5.95 4.69 ± 0.18 
controls 
RDS/HMD · 12 2.45-4.90 4.05 ± 0.21 
t = 2.325, p = 0.0144 
Table 8: Characteristics of survival after pre-BCV thyroxine and TSH. 
Median Area under survival curve 
Experiment Number Mean survival (± sem) survival (ratio referent control) 
Air controls 126 6.87 ± 1.14 hr 3.0 hr 78.38 (1.00) 
Thyroxine at 3 hours 36 19.92 ± 3.07 14.1 115.41 (1.47) 
Thyrotropin at 3 hours 63 15.09 ± 2.91 4.2 117.62 (1.50) 
Table 9: Comparative means and regression slopes for Phases A, B, and C, thyroxine and thyrotropin 
pretreatment at age three hours before bilateral cervical vagotomy at 24 hours compared to air 
only controls. 
Dose level Survival phase Mean survival Mean lung change Regression slope 
Thyroxine Entire run 19.92 (hours) 21.38% 
A -0.0377719 
B -0.0186038 
c -0.1748650 
1 mg/kg A 4.05 8.33 
B 28.32 24.93 
c 50.80 7.00 
10. mg/kg A 3.75 20.77 
B 32.38 29.00 
c 43.64 30.00 
100 mg/kg A 3.50 25.90 
B 36.23 33.33 
c 49.06 29.67 
Air controls Entire run 6.87 7.70 
A 3.30 4.23 -0.139982 
B 24.96 33.63 -0.00926989 
c 55.26 43.00 -0.0243192 
TSH series Entire run 15.09 22.46 
A -0.05339 
B -0.00863854 
c -0.0747942 
Table 10: Survival distribution following thyroidectomy of newborn rabbits by atmospheric 
environment. 
Environment Up to 48 hours Beyond 48 hours Total 
Air Found 6 Found 4 10 
Expected 3.333 Expected 6.667 
Oxygen Found 0 Found 8 8 
Expected 2.667 Expected 5.333 
Total 6 12 18 
Table 11: Thyroxine carrying capacity of serum proteins, clinical study. 
Modality Controls RDSIHMD cases p value 
Thyroid binding globulin 19.857 ± 0,761 mcg/dl 17.408 ± 1.490 mcg/dl 0.0698 
Free thyroxine index 8.029 ± 0.507 7.417 ± 0.365 0.1760 
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